Epigenetic modulation of SPCA2 reverses epithelial to mesenchymal transition in breast cancer cells
Simple Summary The triple receptor negative breast cancer subtype, or TNBC, currently has
no tailored treatment options. TNBC is highly metastatic, associated with high patient …
no tailored treatment options. TNBC is highly metastatic, associated with high patient …
[HTML][HTML] Alterations in the Ca2+ toolkit in oesophageal adenocarcinoma
AL Cutliffe, SL McKenna… - … of Targeted Anti …, 2021 - ncbi.nlm.nih.gov
Aim: To investigate alterations in transcription of genes, encoding Ca 2+ toolkit proteins, in
oesophageal adenocarcinoma (OAC) and to assess associations between gene expression …
oesophageal adenocarcinoma (OAC) and to assess associations between gene expression …
Epigenetic Modulation of SPCA2 Reverses Epithelial to Mesenchymal Transition in Breast Cancer Cells. Cancers 2021, 13, 259
Abstract The secretory pathway Ca 2+-ATPase SPCA2 is a tumor suppressor in triple
receptor negative breast cancer (TNBC), a highly aggressive molecular subtype that lacks …
receptor negative breast cancer (TNBC), a highly aggressive molecular subtype that lacks …